インクレチンの概念
2010年 01月 27日
Incretin Concepts
Zachary T. Bloomgarden, MD
doi: 10.2337/dc10-zb02 Diabetes Care February 2010 vol. 33 no. 2 e20-e25
Central nervous system effects of glucagon-like peptide 1
Cardiac effects of GLP-1
Metabolic effects of GLP-1 mediated by direct action
Possible role of GLP-1 (9-36)
Incretin-based treatment approaches
Exenatide immediate release
Exenatide once weekly
Liraglutide
Other GLP-1 receptor agonists
Oral agents acting via the incretin system
by internalmedicine | 2010-01-27 16:17 | 糖尿病・肥満